Structure Therapeutics Inc. (GPCR) Balance Sheet
As of 2026-06-30 (10-Q), Structure Therapeutics Inc. (GPCR) reported total assets of $1.4B, total liabilities of $71.0M and shareholders' equity of $1.4B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $272.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GPCRStructure Therapeutics Inc.Follow GPCR — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 0.13 | 0.17 | 0.80 | 0.27 | |
| Short-term investments | 0.34 | 0.71 | 0.65 | 1.07 | |
| Current assets | 0.47 | 0.89 | 1.57 | 1.37 | |
| Total assets | 0.48 | 0.90 | 1.58 | 1.43 | |
| Current liabilities | 0.02 | 0.04 | 0.06 | 0.07 | |
| Total liabilities | 0.03 | 0.04 | 0.07 | 0.07 | |
| Shareholders' equity | 0.45 | 0.86 | 1.52 | 1.35 |
USD billions · SEC XBRL
Structure Therapeutics Inc. — questions
- How much cash does Structure Therapeutics Inc. have?
- $272.6M in cash and cash equivalents as of 2026-06-30.
- What are Structure Therapeutics Inc.'s total assets?
- $1.4B as of 2026-06-30.
- What is Structure Therapeutics Inc.'s shareholders' equity?
- $1.4B as of 2026-06-30.
Every figure on this page comes from Structure Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.